Navigation Links
Nanoscale microscope sheds first light on gene repair

Proteins called H2AX act as "first aid" to DNA, among other roles. For the first time, scientists using the world's most powerful light microscope (the only one of its kind in the Americas) have seen how H2AX is distributed in the cell nucleus: in clusters, directing the first aid/repair after DNA injuries to the region where it is really needed.

Many biological processes lie out of the visual reach of scientists. The benefits of high-resolution electron microscopy are often offset by disruptive sample preparation requirements. Light microscopy allows easier sample prep and observations of living cells, but it has limited resolution. By manipulating how light waves behave, however, biophysicists are expanding the limits of light microscopy, and one of the latest advances--the 4Pi microscope--provides never-before-seen views of cellular components, including structures within the nucleus.

In a paper published in the Proceedings of the National Academy of Sciences, Joerg Bewersdorf of the Institute for Molecular Biophysics at The Jackson Laboratory, with collaborators Brian Bennett of the UMass Medical School and Leica Microsystems and Kendall Knight of the UMass Medical School, used the 4Pi microscope to examine the cellular response to a type of severe damage to the genetic material, DNA double-strand breaks. Such breaks provoke a rapid and highly coordinated series of events to identify and repair the damage. The response is critical, and there is an increased risk for cancer, developmental abnormalities and immunological problems when components of the repair processes are defective.

Traditional microbiological and genetics techniques can shed light on the molecular pathways of repair, but they don't address the astonishingly complex three-dimensional structure of the genetic material in the nucleus. 4Pi microscopy allows researchers to actually see the response in three dimensions, at resolutions down to 100 nm. Therefore, the r ole of the physical structures in various processes within the nucleus can now be visualized.

"The general application of these methods will provide unprecedented insights into cellular molecular events," said Bewersdorf. "This study represents a significant advance in our ability to visualize and quantify nuclear proteins in 3D."

Bewersdorf, Bennett and Knight examined a protein called H2AX, a kind of histone. Histones are structural proteins that act as spools around which DNA is wound, and they can also play roles in gene regulation and gene repair. H2AX is an early responder to DNA damage, and its change to what is known as gamma-H2AX is important for the coordination of signaling and repair activities. But it had not been known how H2AX is distributed throughout the nucleus or why its conversion to gamma-H2AX is limited to within a short distance of a break site. By using selective staining techniques and 4Pi visualization, Bewersdorf and colleagues determined that H2AX is distributed in distinct clusters uniformly throughout the nucleus and that the structure of these clusters may determine the boundaries of where gamma-H2AX spreads in response to a break.

"The clusters may provide a platform for the immediate and robust response observed following DNA damage," said Bewersdorf. "Moving forward, we will analyze the localization of the H2AX clusters relative to other nuclear components."
'"/>

Source:Jackson Laboratory


Related biology news :

1. Nanoscale Diagnostic Sets Sights on Alzheimers
2. Nanoscale method for investigating living systems
3. New, unique microscope for nanotech
4. High-resolution light microscope reveals the fundamental mechanisms of nerve communication
5. New light microscope sharpens scientists focus
6. Bacteria collection sheds light on urinary tract infections
7. Sea skate experiment sheds light on human cell transport
8. Bacterial genome sheds light on synthesizing cancer-fighting compounds
9. Newly discovered genetic disease sheds light on bodys water balance
10. Multi-species genome comparison sheds new light on evolutionary processes, cancer mutations
11. Gene discovery sheds light on causes of rare disease, cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/2/2016)... LONDON , June 2, 2016 ... has awarded the 44 million US Dollar project, ... Security Embossed Vehicle Plates including Personalization, Enrolment, and IT Infrastructure ... world leader in the production and implementation of Identity Management ... in January, however Decatur was selected ...
(Date:6/2/2016)... Perimeter Surveillance & Detection Systems, Biometrics & ... & Other Service  The latest report from ... of the global Border Security market . Visiongain ... billion in 2016. Now: In November 2015 ... and hardware technologies for advanced video surveillance. ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: